Integra Lifesciences Holdings (IART) Net Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly Net Margin of 1.18% in Q1 2026, down 200.68% quarter-over-quarter from 0.39% in Q4 2025, and up 543.0% year-over-year from 0.18% in Q1 2025.
Integra Lifesciences Holdings' Net Margin history runs 17 years deep, the most recent figure standing at 1.18% for Q1 2026.
- In Q1 2026, Net Margin rose 543.0% year-over-year to 1.18%; the TTM figure through Mar 2026 stood at 30.15% (down 2837.0% YoY), while the FY2025 annual figure was 31.58%, down 3115.0% from the prior year.
- Net Margin came in at 1.18% for Q1 2026 at Integra Lifesciences Holdings, down from 0.39% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 13.3% in Q4 2022 to a low of 116.47% in Q2 2025.
- A 5-year average of 3.79% and a median of 1.1% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin slumped 11351 bps in 2025 and surged 543 bps in 2026, its largest moves.
- Integra Lifesciences Holdings' Net Margin stood at 13.3% in 2022, then tumbled by 62 bps to 5.0% in 2023, then decreased by 12 bps to 4.39% in 2024, then plunged by 109 bps to 0.39% in 2025, then tumbled by 201 bps to 1.18% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 1.18%, 0.39%, and 1.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | -1.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.18% |
| Dec 31, 2025 | -0.39% |
| Sep 30, 2025 | -1.34% |
| Jun 30, 2025 | -116.47% |
| Mar 31, 2025 | -6.61% |
| Dec 31, 2024 | 4.39% |
| Sep 30, 2024 | -2.81% |
| Jun 30, 2024 | -2.97% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 5.00% |
| Sep 30, 2023 | 5.10% |
| Jun 30, 2023 | 1.10% |
| Mar 31, 2023 | 6.36% |
| Dec 31, 2022 | 13.30% |
| Sep 30, 2022 | 12.96% |
| Jun 30, 2022 | 11.26% |
| Mar 31, 2022 | 8.74% |
| Dec 31, 2021 | 11.19% |
| Sep 30, 2021 | 11.17% |
| Jun 30, 2021 | 8.99% |
| Mar 31, 2021 | 12.61% |
| Dec 31, 2020 | 23.86% |
| Sep 30, 2020 | 8.73% |
| Jun 30, 2020 | -0.14% |
| Mar 31, 2020 | 2.59% |
| Dec 31, 2019 | 3.88% |
| Sep 30, 2019 | -7.28% |
| Jun 30, 2019 | 7.75% |
| Mar 31, 2019 | 9.11% |
| Dec 31, 2018 | 6.56% |
| Sep 30, 2018 | 3.63% |
| Jun 30, 2018 | 3.11% |
| Mar 31, 2018 | 3.08% |
| Dec 31, 2017 | 12.03% |
| Sep 30, 2017 | 1.13% |
| Jun 30, 2017 | 3.84% |
| Mar 31, 2017 | 2.47% |
| Jun 30, 2015 | -3.30% |
| Mar 31, 2015 | -1.65% |
| Dec 31, 2014 | -1.48% |
| Sep 30, 2014 | 0.41% |
| Jun 30, 2014 | 2.45% |
| Mar 31, 2014 | 1.20% |
| Dec 31, 2013 | 28.85% |
| Sep 30, 2013 | -14.22% |
| Jun 30, 2013 | 0.74% |
| Mar 31, 2013 | -3.07% |
| Dec 31, 2012 | 5.96% |
| Sep 30, 2012 | 6.29% |
| Jun 30, 2012 | 4.05% |
| Mar 31, 2012 | 3.41% |
| Dec 31, 2011 | 2.24% |
| Sep 30, 2011 | 5.56% |
| Jun 30, 2011 | 0.36% |
| Mar 31, 2011 | 6.34% |
| Dec 31, 2010 | 9.69% |
| Sep 30, 2010 | 8.83% |
| Jun 30, 2010 | 8.49% |
| Mar 31, 2010 | 8.81% |
| Dec 31, 2009 | -13.49% |
| Sep 30, 2009 | 8.38% |
| Jun 30, 2009 | 6.77% |